Telix Pharmaceuticals Ltd
ASX:TLX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
AU |
|
V
|
Vienna Insurance Group Wiener Versicherung Gruppe AG
F:WSV2
|
AT |
|
Dalaroo Metals Ltd
ASX:DAL
|
AU |
|
A
|
Arras Minerals Corp.
F:9RJ
|
CA |
|
D
|
Dynex Capital Inc
F:DYT1
|
US |
|
Brunello Cucinelli SpA
MIL:BC
|
IT |
|
Prosus NV
OTC:PROSF
|
NL |
|
Tabcorp Holdings Ltd
ASX:TAH
|
AU |
|
Lands' End Inc
NASDAQ:LE
|
US |
|
M
|
Meren Energy Inc
F:AFZ0
|
CA |
|
P
|
Paladin Energy Ltd
DUS:PUR
|
AU |
|
B
|
Boston Scientific Corp
F:BSX
|
US |
|
Transtech Industries Inc
OTC:TRTI
|
US |
|
Asahi Rubber Inc
TSE:5162
|
JP |
|
R
|
RS Group PLC
DUS:ECN
|
UK |
|
R
|
RRIL Ltd
BSE:531307
|
IN |
|
E
|
Expeditors International of Washington Inc
LSE:0IJR
|
US |
|
Aurora Mobile Ltd
NASDAQ:JG
|
CN |
|
Warner Music Group Corp
NASDAQ:WMG
|
US |
|
Siemens AG
F:SIEB
|
DE |
Bankruptcy Probability
Telix Pharmaceuticals Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Telix Pharmaceuticals Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AU |
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
5.3B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
465.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
229.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
187.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
133.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
81.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.2B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
59.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
43.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Telix Pharmaceuticals Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Telix Pharmaceuticals Ltd has total debt of 564.4m USD. This includes both short-term (0 USD) and long-term (564.4m USD) debt.
You can find a full breakdown on its Balance Sheet.